-
Palmitic acid (Hexadecanoic Acid): Protocols and Technical U
2026-06-12
Palmitic acid (hexadecanoic acid, SKU N2456) provides researchers with a high-purity, well-characterized saturated long-chain fatty acid for robust studies of lipid metabolism and protein palmitoylation. It should not be used in protocols requiring aqueous solubility or long-term solution stability, making precise handling essential for reproducible results.
-
Bradykinin in Translational Research: Beyond Vasodilation
2026-06-11
Explore Bradykinin as an endothelium-dependent vasodilator and discover its underappreciated translational value in designing advanced assays for vascular permeability, pain mechanisms, and inflammation. This article offers unique assay strategy insights and an evidence-based outlook for research.
-
Reliable p38α MAPK Inhibition: Scenario-Based Guide to VX-70
2026-06-11
This article delivers practical, evidence-backed insights into deploying VX-702 (SKU A8687) for robust p38α MAPK inhibition in cellular assays. By grounding solutions in real-world laboratory scenarios, it demonstrates how VX-702 from APExBIO overcomes selectivity, reproducibility, and workflow challenges, supporting data-driven advances in inflammation and cardiovascular research.
-
Thioguanine Applications: Protocol Advances in Cancer and Vi
2026-06-10
Thioguanine (6-thioguanine) is a versatile tool for translational researchers tackling cancer, viral inhibition, and inflammatory disease. This guide synthesizes the latest workflow refinements, encapsulation breakthroughs, and troubleshooting strategies, drawing from pivotal nanoparticle studies and APExBIO’s high-purity formulation for reproducible results.
-
Structural Mechanisms of ASCH Domains in N4-Acetylcytidine P
2026-06-10
Meng et al. provide the first high-resolution structural and mechanistic analysis of ASCH domain-containing proteins, revealing how EcYqfB specifically hydrolyzes N4-acetylcytidine nucleoside to cytidine and clarifying its exclusion from direct RNA modification removal. This work advances understanding of enzyme specificity in RNA nucleotide processing and informs assay design in RNA epigenetics research.
-
D-Luciferin as a Precision Bioluminescence Probe in Glioma I
2026-06-09
Discover how D-Luciferin, a premier firefly luciferase substrate, advances bioluminescence imaging and immuno-oncology beyond conventional ATP quantification. Explore novel protocol insights and reference-driven assay strategies for glioma biomarker discovery.
-
Re-evaluating ACE Inhibitor Selectivity: Insights from Amino
2026-06-09
This study systematically compares the inhibitory profiles of various metallopeptidase inhibitors, including classical ACE inhibitors, against key mammalian cell surface aminopeptidases (AP-N, AP-A, AP-W). The findings clarify the selectivity and off-target actions of these inhibitors, with important implications for research on hypertension, heart failure, and peptide metabolism.
-
Sulfur Transport Delays Soybean Nodule Senescence via RNS Co
2026-06-08
A recent study identifies symbiosome sulfur supply as a critical regulator of nodule senescence in soybean, demonstrating that SULTR-mediated sulfur import preserves glutathione levels and limits reactive nitrogen species. These findings offer new avenues for enhancing symbiotic nitrogen fixation and legume productivity through targeted nutrient management and genetic interventions.
-
Tamsulosin in Urological Research: Protocols and Optimizatio
2026-06-08
Tamsulosin, a highly selective α₁A-adrenergic receptor antagonist, streamlines smooth muscle relaxation studies and ureteral stone expulsion workflows for urological and GPCR pathway research. This article offers actionable protocols, troubleshooting insights, and evidence-driven tips to maximize reproducibility and performance, leveraging the latest meta-analytic findings and trusted APExBIO supply.
-
Pertussis Toxin: Applied Immune Modulation and Workflow Insi
2026-06-07
Pertussis toxin is a gold standard AB5-type protein exotoxin for dissecting cAMP-mediated immune modulation, particularly in dendritic cell and T cell signaling studies. This article delivers actionable protocol guidance, troubleshooting best practices, and the latest research-driven workflow innovations for maximizing experimental impact using APExBIO’s high-purity reagent.
-
MDM1 Overexpression Enhances Apoptosis and Chemoradiotherapy
2026-06-06
This study reveals that MDM1 overexpression in colorectal cancer cells increases p53 levels and apoptotic response, significantly improving sensitivity to chemoradiotherapy. The findings position MDM1 as a predictive biomarker and highlight mechanistic links between MDM1, p53 regulation, and apoptosis induction, informing future strategies to overcome treatment resistance.
-
EMD638683: SGK1 Inhibitor Workflows for Vascular and Cancer
2026-06-05
EMD638683, a highly selective SGK1 inhibitor, enables precise modulation of sodium channel activity and actin dynamics in endothelial cells and tumor models. This guide unlocks advanced, evidence-based workflows and troubleshooting strategies for researchers investigating vascular stiffening, hypertension, and cancer proliferation.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance i
2026-06-05
This article examines how pH-responsive nanoparticles enable systemic mRNA delivery to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN expression and inhibiting the PI3K/Akt pathway, the study highlights a promising strategy for enhancing therapeutic response in resistant tumors.
-
Spleen-Targeted Neoantigen mRNA Vaccine Elicits TLS in HCC
2026-06-04
Lin et al. introduce a spleen-targeted neoantigen mRNA vaccine (STNvac) that robustly activates ISG15+ CD8+ T cells and drives formation of tertiary lymphoid structures (TLS) in hepatocellular carcinoma. This study establishes a mechanistic link between organ-targeted mRNA delivery and coordinated antitumor immunity, offering new avenues for immunotherapy design.
-
Precision Protein Quantification: Driving Translational BBB
2026-06-04
Explore how high-sensitivity protein quantification—anchored by the BCA Protein Assay Kit—enables translational researchers to unravel blood–brain barrier (BBB) dysfunction in neuroHIV, as recently elucidated in α7nAChR-driven endothelial pyroptosis. This thought-leadership article connects mechanistic insight to workflow strategy, highlighting evidence-backed protocol parameters, clinical translation, and pitfalls in protein assay selection, with strategic guidance for advancing from cellular models to therapeutic intervention.
453 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page